Austin Health

Title
ANZTCT Position Statement: COVID-19 Management in Haematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T cell Patients.
Publication Date
2023
Author(s)
Perram, Jacinta
Purtill, Duncan
Bajel, Ashish
Butler, Jason
O'Brien, Tracey
The, Benjamin
Gilroy, Nicole
Ho, Phoebe J
Doocey, Richard
Hills, Thomas
Perera, Travis
Douglas, Genevieve
Ramachadran, Shanti
Chee, Lynette
Trotman, Judith
Weinkove, Robert
Keogh, Steven
Fraser, Chris
Cochrane, Tara
Watson, Anne-Marie
Diamond, Peter
Latimer, Maya
Irving, Ian
Blyth, Emily
Cheah, Chan
Cole, Theresa
Milliken, Sam
Yang, Hung
Greenwood, Matthew
Bardy, Peter
Kennedy, Glen
Larsen, Stephen
Conyers, Rachel
Hamad, Nada
Type of document
Journal Article
OrcId
0000-0003-0054-7906
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0003-0213-5470
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0001-8009-4593
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-2668-1399
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-3667-2613
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0001-7929-1450
DOI
10.1111/imj.15978
Abstract
Patients post haematopoietic stem cell transplant or CAR-T cell therapy face significant risk of morbidity and mortality from SARS-CoV19, due to their immunosuppressed state. As case numbers in Australia and New Zealand continue to rise, guidance on management in this high-risk population is needed. Whilst we have learnt much from international colleagues who faced high infection rates early in the pandemic, guidance relevant to local health system structures, medication availability and emerging therapies is essential to equip physicians to optimally manage our patients. This article is protected by copyright. All rights reserved.
Link
link
Citation
Internal Medicine Journal 2023; 53(1)
Jornal Title
Internal Medicine Journal
ISSN
1445-5994

Files:

NameSizeformatDescriptionLink